News Detail
Boston, Massachusetts, 28 May 2019: The US Food and Drug Administration (FDA) may need to reassess how confirmatory trials are conducted after just one-fifth of such trials for cancer drug indications approved via FDA’s accelerated approval pathway have demonstrated improve......
View Details
Source : Regulatory Focus
Related News
- Study links personal care products to increased hormonal disruptions in children (15-09-2024)
- Study Identifies Hundreds of Potential Targets for Cancer Drugs (12-09-2024)
- Protein-lipid particles to deliver genetic medicine (11-09-2024)
- Harnessing bacteriophages as targeted treatments for drug-resistant bacteria (06-09-2024)
- Chinese scientists claim to have developed hydrogel to treat arthritis: Report (03-09-2024)
- Human gut microbiome: A source of new antibiotic peptides (26-08-2024)
- IIT Kanpur-KGMU together developed a special device, to give easily CPR at home (01-08-2024)
- Scientists control bacterial mutations to preserve antibiotic effectiveness (27-07-2024)
- Dual action antibiotic could make bacterial resistance nearly impossible (25-07-2024)
- Metoprolol, Tamsulosin and Bromocriptine combination treatment shows promise in the treatment of retinal degenerations (23-07-2024)